Literature DB >> 21529284

Immunodetection of human double homeobox 4.

Linda N Geng1, Ashlee E Tyler, Stephen J Tapscott.   

Abstract

Double homeobox 4 (DUX4) is a candidate disease gene for facioscapulohumeral dystrophy (FSHD), one of the most common muscular dystrophies characterized by progressive skeletal muscle degeneration. Despite great strides in understanding precise genetics of FSHD, the molecular pathophysiology of the disease remains unclear. One of the major limitations has been the availability of appropriate molecular tools to study DUX4 protein. In the present study, we report the development of five new monoclonal antibodies targeted against the N- and C-termini of human DUX4, and characterize their reactivity using Western blot and immunofluorescence staining. Additionally, we show that expression of the canonical full coding DUX4 induces cell death in human primary muscle cells, whereas the expression of a shorter splice form of DUX4 results in no such toxicity. Immunostaining with these new antibodies reveals a differential effect of two DUX4 isoforms on human muscle cells. These antibodies will provide an excellent tool for investigating the role of DUX4 in FSHD pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21529284      PMCID: PMC3132944          DOI: 10.1089/hyb.2010.0094

Source DB:  PubMed          Journal:  Hybridoma (Larchmt)        ISSN: 1554-0014


  15 in total

1.  A unifying genetic model for facioscapulohumeral muscular dystrophy.

Authors:  Richard J L F Lemmers; Patrick J van der Vliet; Rinse Klooster; Sabrina Sacconi; Pilar Camaño; Johannes G Dauwerse; Lauren Snider; Kirsten R Straasheijm; Gert Jan van Ommen; George W Padberg; Daniel G Miller; Stephen J Tapscott; Rabi Tawil; Rune R Frants; Silvère M van der Maarel
Journal:  Science       Date:  2010-08-19       Impact factor: 47.728

2.  Intracellular trafficking and dynamics of double homeodomain proteins.

Authors:  Cecilia Ostlund; Ruth M Garcia-Carrasquillo; Alexandra Belayew; Howard J Worman
Journal:  Biochemistry       Date:  2005-02-22       Impact factor: 3.162

Review 3.  Facioscapulohumeral dystrophy.

Authors:  Shree Pandya; Wendy M King; Rabi Tawil
Journal:  Phys Ther       Date:  2007-11-06

4.  RNA transcripts, miRNA-sized fragments and proteins produced from D4Z4 units: new candidates for the pathophysiology of facioscapulohumeral dystrophy.

Authors:  Lauren Snider; Amy Asawachaicharn; Ashlee E Tyler; Linda N Geng; Lisa M Petek; Lisa Maves; Daniel G Miller; Richard J L F Lemmers; Sara T Winokur; Rabi Tawil; Silvère M van der Maarel; Galina N Filippova; Stephen J Tapscott
Journal:  Hum Mol Genet       Date:  2009-04-09       Impact factor: 6.150

5.  DUX4c, an FSHD candidate gene, interferes with myogenic regulators and abolishes myoblast differentiation.

Authors:  Darko Bosnakovski; Sarah Lamb; Tugba Simsek; Zhaohui Xu; Alexandra Belayew; Rita Perlingeiro; Michael Kyba
Journal:  Exp Neurol       Date:  2008-08-06       Impact factor: 5.330

Review 6.  Facioscapulohumeral muscular dystrophy.

Authors:  George W Padberg; Baziel Gm van Engelen
Journal:  Curr Opin Neurol       Date:  2009-10       Impact factor: 5.710

Review 7.  Facioscapulohumeral muscular dystrophy.

Authors:  Rabi Tawil
Journal:  Neurotherapeutics       Date:  2008-10       Impact factor: 7.620

8.  The DUX4 gene at the FSHD1A locus encodes a pro-apoptotic protein.

Authors:  Valeria Kowaljow; Aline Marcowycz; Eugénie Ansseau; Cecilia B Conde; Sébastien Sauvage; Christel Mattéotti; Cristina Arias; E Daniel Corona; Nicolás G Nuñez; Oberdan Leo; Ruddy Wattiez; Denise Figlewicz; Dalila Laoudj-Chenivesse; Alexandra Belayew; Frédérique Coppée; Alberto L Rosa
Journal:  Neuromuscul Disord       Date:  2007-06-27       Impact factor: 4.296

9.  Location of facioscapulohumeral muscular dystrophy gene on chromosome 4.

Authors:  C Wijmenga; R R Frants; O F Brouwer; P Moerer; J L Weber; G W Padberg
Journal:  Lancet       Date:  1990-09-15       Impact factor: 79.321

10.  DUX4c is up-regulated in FSHD. It induces the MYF5 protein and human myoblast proliferation.

Authors:  Eugénie Ansseau; Dalila Laoudj-Chenivesse; Aline Marcowycz; Alexandra Tassin; Céline Vanderplanck; Sébastien Sauvage; Marietta Barro; Isabelle Mahieu; Axelle Leroy; India Leclercq; Véronique Mainfroid; Denise Figlewicz; Vincent Mouly; Gillian Butler-Browne; Alexandra Belayew; Frédérique Coppée
Journal:  PLoS One       Date:  2009-10-15       Impact factor: 3.240

View more
  32 in total

1.  Wnt/β-catenin signaling suppresses DUX4 expression and prevents apoptosis of FSHD muscle cells.

Authors:  Gregory J Block; Divya Narayanan; Amanda M Amell; Lisa M Petek; Kathryn C Davidson; Thomas D Bird; Rabi Tawil; Randall T Moon; Daniel G Miller
Journal:  Hum Mol Genet       Date:  2013-07-02       Impact factor: 6.150

2.  DUX4 Suppresses MHC Class I to Promote Cancer Immune Evasion and Resistance to Checkpoint Blockade.

Authors:  Guo-Liang Chew; Amy E Campbell; Emma De Neef; Nicholas A Sutliff; Sean C Shadle; Stephen J Tapscott; Robert K Bradley
Journal:  Dev Cell       Date:  2019-07-18       Impact factor: 12.270

3.  Generation of isogenic D4Z4 contracted and noncontracted immortal muscle cell clones from a mosaic patient: a cellular model for FSHD.

Authors:  Yvonne D Krom; Julie Dumonceaux; Kamel Mamchaoui; Bianca den Hamer; Virginie Mariot; Elisa Negroni; Linda N Geng; Nicolas Martin; Rabi Tawil; Stephen J Tapscott; Baziel G M van Engelen; Vincent Mouly; Gillian S Butler-Browne; Silvère M van der Maarel
Journal:  Am J Pathol       Date:  2012-08-04       Impact factor: 4.307

4.  Myogenic enhancers regulate expression of the facioscapulohumeral muscular dystrophy-associated DUX4 gene.

Authors:  Charis L Himeda; Céline Debarnot; Sachiko Homma; Mary Lou Beermann; Jeffrey B Miller; Peter L Jones; Takako I Jones
Journal:  Mol Cell Biol       Date:  2014-03-17       Impact factor: 4.272

5.  DUX4 activates germline genes, retroelements, and immune mediators: implications for facioscapulohumeral dystrophy.

Authors:  Linda N Geng; Zizhen Yao; Lauren Snider; Abraham P Fong; Jennifer N Cech; Janet M Young; Silvere M van der Maarel; Walter L Ruzzo; Robert C Gentleman; Rabi Tawil; Stephen J Tapscott
Journal:  Dev Cell       Date:  2011-12-29       Impact factor: 12.270

6.  The DUX4 homeodomains mediate inhibition of myogenesis and are functionally exchangeable with the Pax7 homeodomain.

Authors:  Darko Bosnakovski; Erik A Toso; Lynn M Hartweck; Alessandro Magli; Heather A Lee; Eliza R Thompson; Abhijit Dandapat; Rita C R Perlingeiro; Michael Kyba
Journal:  J Cell Sci       Date:  2017-09-21       Impact factor: 5.285

7.  Smchd1 haploinsufficiency exacerbates the phenotype of a transgenic FSHD1 mouse model.

Authors:  Jessica C de Greef; Yvonne D Krom; Bianca den Hamer; Lauren Snider; Yosuke Hiramuki; Rob F P van den Akker; Kelsey Breslin; Miha Pakusch; Daniela C F Salvatori; Bram Slütter; Rabi Tawil; Marnie E Blewitt; Stephen J Tapscott; Silvère M van der Maarel
Journal:  Hum Mol Genet       Date:  2018-02-15       Impact factor: 6.150

Review 8.  Emerging preclinical animal models for FSHD.

Authors:  Angela Lek; Fedik Rahimov; Peter L Jones; Louis M Kunkel
Journal:  Trends Mol Med       Date:  2015-03-20       Impact factor: 11.951

9.  Dominant lethal pathologies in male mice engineered to contain an X-linked DUX4 transgene.

Authors:  Abhijit Dandapat; Darko Bosnakovski; Lynn M Hartweck; Robert W Arpke; Kristen A Baltgalvis; Derek Vang; June Baik; Radbod Darabi; Rita C R Perlingeiro; F Kent Hamra; Kalpna Gupta; Dawn A Lowe; Michael Kyba
Journal:  Cell Rep       Date:  2014-08-28       Impact factor: 9.423

10.  Expression of DUX4 in zebrafish development recapitulates facioscapulohumeral muscular dystrophy.

Authors:  Hiroaki Mitsuhashi; Satomi Mitsuhashi; Taylor Lynn-Jones; Genri Kawahara; Louis M Kunkel
Journal:  Hum Mol Genet       Date:  2012-10-29       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.